Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Analysis of SUMOylated proteins using SUMO-traps.

Da Silva-Ferrada E, Xolalpa W, Lang V, Aillet F, Martin-Ruiz I, de la Cruz-Herrera CF, Lopitz-Otsoa F, Carracedo A, Goldenberg SJ, Rivas C, England P, Rodríguez MS.

Sci Rep. 2013;3:1690. doi: 10.1038/srep01690.

2.

Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47.

Weinstock J, Wu J, Cao P, Kingsbury WD, McDermott JL, Kodrasov MP, McKelvey DM, Suresh Kumar KG, Goldenberg SJ, Mattern MR, Nicholson B.

ACS Med Chem Lett. 2012 Sep 11;3(10):789-92. doi: 10.1021/ml200276j. eCollection 2012 Oct 11.

3.

Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.

Altun M, Kramer HB, Willems LI, McDermott JL, Leach CA, Goldenberg SJ, Kumar KG, Konietzny R, Fischer R, Kogan E, Mackeen MM, McGouran J, Khoronenkova SV, Parsons JL, Dianov GL, Nicholson B, Kessler BM.

Chem Biol. 2011 Nov 23;18(11):1401-12. doi: 10.1016/j.chembiol.2011.08.018.

4.

The ubiquitin-specific protease USP34 regulates axin stability and Wnt/β-catenin signaling.

Lui TT, Lacroix C, Ahmed SM, Goldenberg SJ, Leach CA, Daulat AM, Angers S.

Mol Cell Biol. 2011 May;31(10):2053-65. doi: 10.1128/MCB.01094-10. Epub 2011 Mar 7.

5.

Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay format.

Tian X, Isamiddinova NS, Peroutka RJ, Goldenberg SJ, Mattern MR, Nicholson B, Leach C.

Assay Drug Dev Technol. 2011 Apr;9(2):165-73. doi: 10.1089/adt.2010.0317. Epub 2010 Dec 6.

6.

Strategies for the identification of ubiquitin ligase inhibitors.

Goldenberg SJ, Marblestone JG, Mattern MR, Nicholson B.

Biochem Soc Trans. 2010 Feb;38(Pt 1):132-6. doi: 10.1042/BST0380132. Review.

7.

Strategies for the identification of novel inhibitors of deubiquitinating enzymes.

Goldenberg SJ, McDermott JL, Butt TR, Mattern MR, Nicholson B.

Biochem Soc Trans. 2008 Oct;36(Pt 5):828-32. doi: 10.1042/BST0360828. Review.

8.

Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities.

Nicholson B, Leach CA, Goldenberg SJ, Francis DM, Kodrasov MP, Tian X, Shanks J, Sterner DE, Bernal A, Mattern MR, Wilkinson KD, Butt TR.

Protein Sci. 2008 Jun;17(6):1035-43. doi: 10.1110/ps.083450408. Epub 2008 Apr 18.

9.

Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.

Major MB, Camp ND, Berndt JD, Yi X, Goldenberg SJ, Hubbert C, Biechele TL, Gingras AC, Zheng N, Maccoss MJ, Angers S, Moon RT.

Science. 2007 May 18;316(5827):1043-6.

10.

The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation.

Angers S, Thorpe CJ, Biechele TL, Goldenberg SJ, Zheng N, MacCoss MJ, Moon RT.

Nat Cell Biol. 2006 Apr;8(4):348-57. Epub 2006 Mar 19.

PMID:
16547521
11.

Structure of the Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the assembly of the multisubunit cullin-dependent ubiquitin ligases.

Goldenberg SJ, Cascio TC, Shumway SD, Garbutt KC, Liu J, Xiong Y, Zheng N.

Cell. 2004 Nov 12;119(4):517-28.

12.

Comparison of functional aspects of the coagulation cascade in human and sea turtle plasmas.

Soslau G, Wallace B, Vicente C, Goldenberg SJ, Tupis T, Spotila J, George R, Paladino F, Whitaker B, Violetta G, Piedra R.

Comp Biochem Physiol B Biochem Mol Biol. 2004 Aug;138(4):399-406.

PMID:
15325341
13.
14.

A micromethod to measure platelet aggregation and atp release by impedance.

Goldenberg SJ, Veriabo NJ, Soslau G.

Thromb Res. 2001 Jul 1;103(1):57-61.

PMID:
11434946

Supplemental Content

Loading ...
Support Center